Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Zagari

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Seminars in Oncology|June 26, 2002
Age, anemia, and fatigueMatti S Aapro, David Cella, Martin Zagari
Kidney International|February 12, 2004
Impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysisMichael Jones, Lloyd Ibels, Brad Schenkel, et al.
The Oncologist|February 27, 2003
Baseline and early treatment factors are not clinically useful for predicting individual response to erythropoietin in anemic cancer patientsTimothy J Littlewood, Martin Zagari, Christopher Pallister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2011
Integrating pain metrics into oncology clinical trialsCharles S Cleeland, Ann O'Mara, Martin Zagari, et al.
Pain Medicine (Malden, Mass.)|January 10, 2014
Assessing analgesic use in patients with advanced cancer: development of a new scale--the Analgesic Quantification AlgorithmKaren C Chung, Arie Barlev, Ada H Braun, et al.
Psychiatry Research|April 18, 2025
Quantifying the independent impact of social determinants of health and posttraumatic stress disorder on resource utilization and health outcomes in civiliansKatarina Irwin, Martin Zagari, Heidi C Waters, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Seminars in Oncology|June 26, 2002
Age, anemia, and fatigueMatti S Aapro, David Cella, Martin Zagari
Kidney International|February 12, 2004
Impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysisMichael Jones, Lloyd Ibels, Brad Schenkel, et al.
The Oncologist|February 27, 2003
Baseline and early treatment factors are not clinically useful for predicting individual response to erythropoietin in anemic cancer patientsTimothy J Littlewood, Martin Zagari, Christopher Pallister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2011
Integrating pain metrics into oncology clinical trialsCharles S Cleeland, Ann O'Mara, Martin Zagari, et al.
Pain Medicine (Malden, Mass.)|January 10, 2014
Assessing analgesic use in patients with advanced cancer: development of a new scale--the Analgesic Quantification AlgorithmKaren C Chung, Arie Barlev, Ada H Braun, et al.
Psychiatry Research|April 18, 2025
Quantifying the independent impact of social determinants of health and posttraumatic stress disorder on resource utilization and health outcomes in civiliansKatarina Irwin, Martin Zagari, Heidi C Waters, et al.
Pageof 1